280
EQUINE VETERINARY EDUCATION / AE / MAY 2019
concentrations and clinical response in horses treated for equine Cushing’s disease with cyproheptadine or pergolide. Equine Vet. J. 34, 679-685.
Peters, D.F., Erfle, J.B. and Slobojan, G.T. (1995) Low-dose pergolide mesylate treatment for equine hypophyseal adenomas (Cushing’s syndrome). Proc. Am. Assoc. Equine Practnrs. 41, 154-155.
Rohrbach, B.W., Stafford, J.R., Clermont, R.S., Reed, S.M., Schott, H.C. 2nd and Andrews, F.M. (2012) Diagnostic frequency, response to therapy,
and long-term prognosis among horses and ponies with pituitary par intermedia dysfunction, 1993-2004. J. Vet.
Intern.Med. 26, 1027-1034.
Schott, H.C., Coursen, C.L., Eberhart, S.W., Nachreiner, R.J., Refsal, K.R., Ewart, S.L. and Marteniuk, J.V. (2001) The Michigan Cushing’s Project. Proc. Am. Assoc. Equine Practnrs. 47, 22-24.
Spelta, C.W. and Axon, J.E. (2012) Case series of equine pituitary pars intermedia dysfunction in a tropical climate. Aust. Vet. J. 90, 451- 456.
Three days of connections, learnings and lectures you won’t want to miss!
More than twenty different topics delivers by the internationally recognized speakers!
16TH WEVA CONGRESS OCTOBER 3-5, 2019 VERONA, ITALY
KEY DATES
Deadline for abstract submission Early registration deadline Regular registration deadline
March 31st, 2019 May 26th, 2019 June 30th, 2019
www.weva2019.eu
© 2018 EVJ Ltd
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84
